Nymox Pharmaceutical (NYMX) NX-1207 Symposium May 5 in San Diego at Annual Meeting of American Urological Association at San Diego Convention Center
4/30/2013 2:31:41 PM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
HASBROUCK HEIGHTS, N.J., April 30, 2013 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to announce further information about the upcoming Symposium on NX-1207 to be held on May 5 at 3 p.m. in San Diego at the Annual Meeting of the American Urological Association at the San Diego Convention Center. The symposium is entitled, "Clinical studies of NX-1207: Phase 3 Injectable for BPH (Phase 2 for Prostate Cancer)," and will be held at the ICU Theater, Science and Convention Hall #2233 at the Convention Center.
Help employers find you! Check out all the jobs and post your resume.